Rueil-Malmaison, France, 14-1-2014 — /EuropaWire/ — VINCI announces the successful placement by ASF (Autoroutes du Sud de la France) of a €600 million bond issue maturing in January 2024, with an annual coupon of 2.95%. The issue was approximately 4 times oversubscribed, thus … Read the full press release
Posted in Business, Construction, Financial, France, Infrastructure & Utilities, Investment
Tagged ASF, ASF (Autoroutes du Sud de la France), Autoroutes du Sud de la France, Banca IMI, Bond issue, Crédit Agricole CIB, investors, Lloyds Bank, Mizuho, Morgan Stanley, oversubscribed, Santander GBM, VINCI
Paris, France, 12-11-2013 — /EuropaWire/ — Sanofi (EURONEXT: SAN and NYSE: SNY) announces that it has successfully priced its offering of EUR 1 billion of notes, due 2023, bearing interest at an annual rate of 2.50%. The issue is drawn under the Company’s Euro … Read the full press release
Posted in Business, Financial, France, Healthcare, Investment, Pharma & Biotech, Science
Tagged bond, bookrunners, Citi, EURONEXT: SAN, HSBC, Laurence Bollack, NYSE: SNY, Sanofi, Santander GBM, Sébastien Martel, The Royal Bank of Scotland
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
